Going Up in a Down Market ( DNDN ) ( ZERO ) ( CLDX ) ( INHX )
momentumtraders Newsletter
~~~~~~~~~~~~~~~~~~~~~~~~~~
NOVEMBER 21, 2011 ~~~~~~~~~~~~~~~~~~~~~~~~~~
*
*
buttonabout buttonadvert buttonnetwork buttonmorealerts *
*
HOTM ) ~~~~~~~~~~~~~~~~~~~~~~~~~~
*************
PRE-OPEN STOCK WATCH *************
U.S. stock index futures were sharply lower on Monday, extending the previous week`s losses as a congressional “super committee” was expected to concede defeat in its bid to lower the deficit.
The committee`s co-chairs will issue a statement later Monday, declaring the bipartisan committee was unable to reach a deficit-reduction deal, according to sources, and had failed to bridge deep divides over taxes and spending.
The developments add another degree of uncertainty to a market besieged by global headwinds, although the failure isn`t expected to affect the country`s credit rating.
Pharmasset agreed to be acquired by Gilead for $137 a share in cash.
VRUS soars 86 percent and GILD is down 6 percent before the bell.
*************
DNDN – NEWS ALERT DNDN – BREAKING $8.75 PRE-OPEN SEATTLE–(BUSINESS WIRE)– Dendreon Corporation today announced the Centers for Medicare and Medicaid Services (CMS) updated their coverage policy to now cover the infusion costs associated with the administration of PROVENGE® (sipuleucel-T).
With this decision, the coverage of PROVENGE is now consistent with all other infused biologics.
*************
ZERO – NEWS ALERT ZERO – $0.31 STWA Delivers Scheduled License Payments to Temple University Company Secures Position as Exclusive Worldwide Rights Holder of Key Technologies SANTA BARBARA, CA–(Marketwire -11/21/11)- Ensuring continued rights to its platform technology, STWA, Inc. (OTC.BB: ZERO.OB – News) (“STWA” or the “Company”), an innovative company creating technology focused on energy efficiency of large-scale energy production and improved fuel economy for diesel fleets, announced today that is has delivered the second of three scheduled license payments to Temple University per its two exclusive worldwide licensing agreements executed on August 9, 2011.
The exclusive licensing agreement covers STWA`s Applied Oil Technology (AOT(TM)) crude oil viscosity reduction technology and ELEKTRA(TM) for improved diesel engine efficiency, as well as future advancements to the technology through collaborative R&D between STWA and Temple University.
“Since the execution of our new exclusive worldwide licensing agreement with Temple University in August, we have delivered on our licensing payments, as well as a major development milestone by proving, as reported by the U.S. Department of Energy, AOT(TM) increases pipeline efficiencies by 13.14% to 13.55% when AOT(TM) was running at just one-third of its intended power capacity,” stated STWA Chairman and CEO Mr. Cecil Bond Kyte. “We are moving forward with our next development milestones and look forward to continuing our very productive collaboration with Dr. Tao, Chairman of Temple University`s Physics Department, and Temple`s office of Technology Development and Commercialization.” Stephen G. Nappi, Director of Technology Development and Commercialization at Temple University added, “We are pleased with STWA`s ability to advance the applied oil and fuel injection technologies beyond the laboratory setting to field-based proof-of-concept.
In addition to achieving these significant development milestones, including the favorable results reported by the U.S. Department of Energy`s Rocky Mountain Oilfield Testing Center, STWA continues to fulfill its obligations under our exclusive license agreements.
We look forward to building from this momentum to optimize performance of these technologies andready them for deployment in the marketplace.” About STWA, Inc.
STWA, Inc. (OTC.BB:
ZERO.OB – News) is an innovative company creating technology focused on energy efficiency of large-scale energy production and improved fuel economy for diesel fleets.
The Company`s Patented and Patent Pending technologies, including AOT(TM) (Applied Oil Technology), under development with Temple University, and ELEKTRA(TM) (for Improved Diesel Engine Efficiency), provide efficient and cost-effective means of improving the efficacy of crude oil transport and diesel engine efficiency to assist in meeting global increasing energy demands and emission quality standards.
Applications include: (AOT(TM)) Crude oil extraction & delivery systems, including oil platforms, oil fields and pipeline transmission systems. (ELEKTRA(TM)) Diesel trucks, trains, marine vessels, military fleets and jet turbines.
More information available at: http://www.stwa.com *************
CLDX – NEWS ALERT CLDX – HITTING $3 PRE-OPEN NEEDHAM, Mass.–(BUSINESS WIRE)– Celldex Therapeutics, Inc. (NASDAQ: CLDX – News) today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
The data showed a final median OS of 24.6 months from diagnosis, which is significantly better than 15.2 months for a historical cohort of patients selected to match ACT III eligibility criteria.
The median OS data obtained from the 31 centers participating in the ACT III study are very consistent with two previous smaller studies with rindopepimut in GB (ACTIVATE and ACT II) conducted at M.D. Anderson and Duke University which showed 24.6 and 24.4 month median OS, respectively.
These data were described in an oral presentation at the 16th Annual Meeting of The Society for Neuro-Oncology (SNO) in Orange County, CA by the lead investigator on the study, Dr. Rose Lai.*************
INHX – ANOTHER BIG JUMP INHX – BREAKING $11.50 PRE-OPEN NEW YORK, NY–(Marketwire -11/08/11)- Biotech companies focused on treatment for Hepatitis C have been on the upswing in recent weeks as a combination of acquisitions and positive test results has raised investor interest.
While the FDA approved two Hepatitis C drugs earlier this year — the first treatment breakthrough in two decades — newer drugs working through the approval process are reported to have better cure rates and reduced side effects.
The Bedford Report examines the outlook for companies in the biotechnology industry and provides investment research on Inhibitex, Inc. (NASDAQ: INHX – News) and Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX – News).
Access to the full company reports can be found at:
www.bedfordreport.com/INHX www.bedfordreport.com/VRTX *************
~~~~~~~~~~~~~~~~~~~~~~~~~~
hototclogo1 stlogo1 drstockpick pennystockdd VISIT qstockssmall ADVERTISEMENT / ALERT SERVICE ONLY Visit www.momentumtraders.net for more disclosure info …
NEVER – Make any Investment Decision based on any information produced in an e-mail newsletter and / or website or any other media format…
ALWAYS – Do your own homework and make Investment Decisions carefully and after personal due diligence.
MomentumTraders.net is a subscription based Internet Forum for our members to participate through e-mails to bring stock market activity to the attention of the entire membership.
MomentumTraders.net does accept advertisement fees for distribution of corporate information to our membership. The paid advertisements often fall under the category of a Company Spotlight. The paid advertisements almost entirely consist of small OTCBB and Pink Sheet Companies and therefore fall under the category of High Risk Potential.
The Information contained within this Web site, e-mail transmissions, faxes, and recorded voice messages (hereinafter collectively referred to as “Information”) are not solicitations to buy, sell, or hold any securities mentioned.
BE AWARE Assume that the information about these companies is not trustworthy unless you can prove otherwise through your own independent research.
The Information should not be used as the sole basis for making any investment decision.
Readers are urged to make a complete review of the companies mentioned, which should include, but is not limited to, each company`s quarterly and annual reports, all SEC filings, and press releases.
The information in this newsletter/website should be viewed just as you would view a television commercial or a magazine ad… This is NOT the place to make investment decisions, NEVER buy or sell stocks based on any newsletter or website information sheet etc…
Readers should do their own due diligence prior to investing in any securities.
MomentumTraders.net is NOT a registered investment advisor or a broker dealer and is not selling investment advice.
Estimates, assumptions and other forward-looking Information are subject to the limits of forecasting. Actual future developments may differ due to many factors.
BE AWARE that many companies within these newsletters have considerable ongoing concern issues and may be in dire straights due to lack of funding… These companies may be on the verge of delisting, bankruptcy and worse.
BE AWARE… Often times, small and thinly traded companies will hire large groups of investment newsletters in order to increase their exposure and daily volumes in order to facilitate selling and/or to raise capital… Often times, these large investment newsletters are paid with large blocks of free trading shares and will increase the risks of dilution and heavy selling/price loss of the small and thinly traded company.
MomentumTraders.net derives its revenues from banner advertising and membership fees for the momentum alert service, as well as from Corporate Profiles and Consulting Programs, and does with full disclosure accept gifts, promotional items, and or compensation from companies that are profiled or mentioned.
MomentumTraders.net and its affiliates WILL buy, sell, and hold stock received from third parties as compensation for representing client companies, This should be viewed as a conflict of interest and all alerts should be viewed as commercial advertisement and NOT as any type of investment information.
MomentumTraders.net has received compensation from third parties and or companies for consulting information for the following stocks.
MomentumTraders.net has no relationship with any third parties and or companies other than as an advertisement consulting business to advertisement consulting client relationship.
All companies who pay MomentumTraders.net with shares of stock do so with agreement that by the act of advertising and or consulting with us that any equity based compensation under the Agreement is not and shall not be the result of issuance of shares under Form S-8 or other similar registration and that such compensation has been fully paid and is non-assessable.
MomentumTraders.net reserves the right to trade in any securities mentioned within e-mails and on site.
MomentumTraders.net may buy and sell securities at any time before, during or after being placed in e-mail or on website.
All Information, including any analysis or opinion, is believed to be reliable, and is presented in good faith; but no representation or warranty, expressed or implied, is made as to its accuracy, completeness, or correctness.
BE AWARE…Often times, newsletters may add content to suggest revenue increases, income projections, contract expansions and other projected positive developments…This often is not based in fact, and often is misleading.
MomentumTraders.net is not responsible for any content that may be issued from newsletters that we may outsource for distribution of press releases and information sheets etc, on any company.
MomentumTraders.net is not responsible for any claims made by any companies profiled.
The recipient of any Information should understand that changes may occur in the affairs of companies profiled since the date of profiling.
We reserve the right to make improvements to, or correct any content, omissions, or errors without notice.
MomentumTraders.net is not liable for any losses or damages, monetary or otherwise, which may result from the content of the Information.
~~~~~~~~~~~~~~~~~~~~~~~~~~
Related posts:
- Pre-Open Stock Watch ( AHCI ) ( ZERO ) ( YHOO ) 07/29/2011
- Pre-Open Stock Watch ( AHCI ) ( ZERO ) ( YHOO ) 07/29/2011
- Pre-Open Stock Movers ( ZERO ) ( ZOOM ) & ( MCVE ) News Alerts
- Pre-Open Stock Movers ( ZERO ) ( PEIX ) ( MPET ) Markets Climb
- Recent Alerts Continue Upward – ( PEIX ) ( SAPX ) ( ZERO ) Updates